Literature DB >> 20936937

Disorders of bone remodeling.

Xu Feng1, Jay M McDonald.   

Abstract

The skeleton provides mechanical support for stature and locomotion, protects vital organs, and controls mineral homeostasis. A healthy skeleton must be maintained by constant bone modeling to carry out these crucial functions throughout life. Bone remodeling involves the removal of old or damaged bone by osteoclasts (bone resorption) and the subsequent replacement of new bone formed by osteoblasts (bone formation). Normal bone remodeling requires a tight coupling of bone resorption to bone formation to guarantee no alteration in bone mass or quality after each remodeling cycle. However, this important physiological process can be derailed by a variety of factors, including menopause-associated hormonal changes, age-related factors, changes in physical activity, drugs, and secondary diseases, which lead to the development of various bone disorders in both women and men. We review the major diseases of bone remodeling, emphasizing our current understanding of the underlying pathophysiological mechanisms.

Entities:  

Mesh:

Year:  2011        PMID: 20936937      PMCID: PMC3571087          DOI: 10.1146/annurev-pathol-011110-130203

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  143 in total

Review 1.  Boning up on Wolff's Law: mechanical regulation of the cells that make and maintain bone.

Authors:  Jan-Hung Chen; Chao Liu; Lidan You; Craig A Simmons
Journal:  J Biomech       Date:  2009-10-08       Impact factor: 2.712

Review 2.  Bone modeling and remodeling.

Authors:  Ego Seeman
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

Review 3.  Calmodulin-an often-ignored signal in osteoclasts.

Authors:  John P Williams; Keith Micoli; Jay M McDonald
Journal:  Ann N Y Acad Sci       Date:  2010-03       Impact factor: 5.691

Review 4.  Update in male osteoporosis.

Authors:  Sundeep Khosla
Journal:  J Clin Endocrinol Metab       Date:  2010-01       Impact factor: 5.958

5.  Central control of fever and female body temperature by RANKL/RANK.

Authors:  Reiko Hanada; Andreas Leibbrandt; Toshikatsu Hanada; Shiho Kitaoka; Tomoyuki Furuyashiki; Hiroaki Fujihara; Jean Trichereau; Magdalena Paolino; Fatimunnisa Qadri; Ralph Plehm; Steffen Klaere; Vukoslav Komnenovic; Hiromitsu Mimata; Hironobu Yoshimatsu; Naoyuki Takahashi; Arndt von Haeseler; Michael Bader; Sara Sebnem Kilic; Yoichi Ueta; Christian Pifl; Shuh Narumiya; Josef M Penninger
Journal:  Nature       Date:  2009-11-26       Impact factor: 49.962

6.  Gene expression profile in osteoclasts from patients with Paget's disease of bone.

Authors:  Laetitia Michou; Estelle Chamoux; Julie Couture; Jean Morissette; Jacques P Brown; Sophie Roux
Journal:  Bone       Date:  2009-11-17       Impact factor: 4.398

Review 7.  Paget disease: when to treat and when not to treat.

Authors:  Frederick R Singer
Journal:  Nat Rev Rheumatol       Date:  2009-08-04       Impact factor: 20.543

Review 8.  Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis.

Authors:  E Michael Lewiecki
Journal:  J Womens Health (Larchmt)       Date:  2009-10       Impact factor: 2.681

Review 9.  Bone disease after renal transplantation.

Authors:  Hartmut H Malluche; Marie-Claude Monier-Faugere; Johann Herberth
Journal:  Nat Rev Nephrol       Date:  2009-11-17       Impact factor: 28.314

10.  Myeloma cell-induced disruption of bone remodelling compartments leads to osteolytic lesions and generation of osteoclast-myeloma hybrid cells.

Authors:  Thomas L Andersen; Kent Søe; Teis E Sondergaard; Torben Plesner; Jean-Marie Delaisse
Journal:  Br J Haematol       Date:  2009-11-16       Impact factor: 6.998

View more
  327 in total

1.  TRAF family member-associated NF-κB activator (TANK) is a negative regulator of osteoclastogenesis and bone formation.

Authors:  Kenta Maruyama; Tatsukata Kawagoe; Takeshi Kondo; Shizuo Akira; Osamu Takeuchi
Journal:  J Biol Chem       Date:  2012-07-06       Impact factor: 5.157

2.  NaF18-PET/CT Imaging of Secondary Hyperparathyroidism.

Authors:  Aung Zaw Win; Carina Mari Aparici
Journal:  Nucl Med Mol Imaging       Date:  2015-01-23

Review 3.  The Histochemistry and Cell Biology omnium-gatherum: the year 2015 in review.

Authors:  Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2016-02-15       Impact factor: 4.304

Review 4.  Gone Caving: Roles of the Transcriptional Regulators YAP and TAZ in Skeletal Development.

Authors:  Christopher D Kegelman; Joseph M Collins; Madhura P Nijsure; Emily A Eastburn; Joel D Boerckel
Journal:  Curr Osteoporos Rep       Date:  2020-10       Impact factor: 5.096

Review 5.  Osteoclasts: New Insights.

Authors:  Xu Feng; Steven L Teitelbaum
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

6.  The IVVY Motif and Tumor Necrosis Factor Receptor-associated Factor (TRAF) Sites in the Cytoplasmic Domain of the Receptor Activator of Nuclear Factor κB (RANK) Cooperate to Induce Osteoclastogenesis.

Authors:  Joel Jules; Shunqing Wang; Zhenqi Shi; Jianzhong Liu; Shi Wei; Xu Feng
Journal:  J Biol Chem       Date:  2015-08-14       Impact factor: 5.157

7.  Intrafibrillar, bone-mimetic collagen mineralization regulates breast cancer cell adhesion and migration.

Authors:  Siyoung Choi; Jens Friedrichs; Young Hye Song; Carsten Werner; Lara A Estroff; Claudia Fischbach
Journal:  Biomaterials       Date:  2018-05-07       Impact factor: 12.479

8.  Effect of bisphosphonates treatment on cytokine imbalance between TH17 and Treg in osteoporosis.

Authors:  Roba M Talaat; Asmaa Sidek; Ahmed Mosalem; Ahmed Kholief
Journal:  Inflammopharmacology       Date:  2015-04-25       Impact factor: 4.473

Review 9.  Nuclear receptors in bone physiology and diseases.

Authors:  Yuuki Imai; Min-Young Youn; Kazuki Inoue; Ichiro Takada; Alexander Kouzmenko; Shigeaki Kato
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

10.  E-selectin ligand 1 regulates bone remodeling by limiting bioactive TGF-β in the bone microenvironment.

Authors:  Tao Yang; Ingo Grafe; Yangjin Bae; Shan Chen; Yuqing Chen; Terry K Bertin; Ming-Ming Jiang; Catherine G Ambrose; Brendan Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.